Rockefeller Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Rockefeller Capital Management's HAE Position: Q3 2026 in Review
Rockefeller Capital Management increased its Haemonetics (HAE) stake by 76% in Q3 2026, buying an estimated $37.4K and bringing the position to 928 shares worth $97.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3088.
Rockefeller Capital Management first reported a position in HAE in Q1 2019 and has held it in 16 quarters since. 354 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Rockefeller Capital Management held 928 shares of Haemonetics worth $97.7K as of Q3 2026.
- Rockefeller Capital Management bought 402 Haemonetics shares in Q3 2026, an estimated $37.4K.
- Haemonetics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3088 holding.
- Rockefeller Capital Management first reported a position in Haemonetics in Q1 2019 and has held it in 16 quarters since.
- 354 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.